Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280
تينيت للرعاية الصحية
Tenet Healthcare Corporation THC | 0.00 |
Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:
THC) with a Neutral and raises the price target from $210 to $280.
